Value of MR DWI combined with serum ApoA-1 level in predicting the curative effect of chemoradiotherapy on NSCLC patients
-
摘要:
目的探究磁共振弥散加权成像(MR DWI)结合血清载脂蛋白A-1(ApoA-1)水平在预测非小细胞肺癌(NSCLC)患者放化疗疗效的价值。 方法选取2019年12月~2020年12月收治的120例NSCLC放化疗患者作为研究对象,患者治疗前后均行DWI检查以及血清ApoA-1水平测定,比较治疗前后DWI指标、ApoA-1水平,分析DWI指标与ApoA-1水平相关性;评估患者疗效,分析治疗前后DWI影像学表现,比较不同疗效治疗2个周期患者DWI指标、血清ApoA-1水平,分析DWI指标、血清ApoA-1水平对于患者疗效预测价值。 结果患者治疗后ADC值、ApoA-1水平较治疗前上升(P < 0.05);随着治疗周期增加,ADC值、ApoA-1水平逐渐上升,差异有统计学意义(P < 0.05);AFC值与ApoA-1水平显示为正相关关系(r=0.633,P < 0.05);有效组患者ADC值、ApoA-1水平高于无效组(P < 0.05);ROC曲线显示ADC值、ApoA-1用于预测患者疗效的AUC值分别为0.587、0.786,两指标联合AUC值为0.899。 结论NSCLC患者应用MR DWI结合血清ApoA-1水平可以有效提高对于患者放化疗疗效预测价值,有一定临床应用价值。 Abstract:ObjectiveTo explore the value of magnetic resonance diffusion weighted imaging(MR DWI)combined with level ofserum apolipoprotein A-1(ApoA-1)in predicting the curative effect of chemoradiotherapy on patients with non-small celllung cancer(NSCLC). MethodsA total of 120 NSCLC patients who underwent chemoradiotherapy and admitted fromDecember 2019 to December 2020 were enrolled.All patients underwent DWI examination and were tested for serum ApoA-1before and after treatment.DWI indexes and ApoA-1 level before and after treatment were compared.The correlation betweenDWI indexes and ApoA-1 level were analyzed.The curative effect on patients was evaluated.DWI imaging findings beforeand after treatment were analyzed.DWI indexes and level of serum ApoA-1 were compared among patients with differentcurative effect after 2 courses.Predictive value DWI indexes and serum ApoA-1 for curative effects were analyzed. ResultsAfter treatment, ADC and ApoA-1 level were significantly increased(P < 0.05).As the increase of treatment cycle, ADC valueand ApoA-1 level were gradually increased, and the differences were significant(P < 0.05).AFC value was positively correlatedwith ApoA-1(r=0.633, P < 0.05).ADC value and ApoA-1 level in effective group were significantly higher than those inineffective group(P < 0.05).ROC curves showed that AUC values of ADC value, ApoA-1 and their combination for predictingcurative effect were 0.587, 0.786 and 0.899, respectively. ConclusionThe application of MR DWI combined with level of serumApoA-1 can effectively improve the predictive value for curative effect of chemoradiotherapy on NSCLC patients. -
表 1 治疗前后DWI指标、ApoA-1水平比较
Table 1. Comparison of DWI indexes and ApoA-1 level before and after treatment (Mean±SD)
指标 治疗前 治疗1个周期 治疗2个周期 F P ADC值(×10-3 mm2/s) 1.18±0.24 1.49±0.31a 1.59±0.22ab 81.405 < 0.001 ApoA-1(g/L) 0.94±0.16 1.22±0.24a 1.43±0.34ab 109.437 < 0.001 aP < 0.05 vs治疗前;bP < 0.05 vs治疗1个周期. 表 2 不同疗效患者治疗后2周DWI指标、血清ApoA-1水平比较
Table 2. Comparison of DWI indexes and level of serum ApoA-1 among patients with different curative effect at 2 weeks after treatment (Mean±SD)
组别 ADC值(×10-3 mm2/s) ApoA-1(g/L) 有效组(n=32) 1.42±0.39 1.23±0.34 无效组(n=88) 1.09±0.43 0.83±0.37 t 3.807 5.347 P < 0.001 < 0.001 表 3 DWI指标、ApoA-1水平用于预测患者疗效价值分析
Table 3. Predictive value of DWI indexes and ApoA-1 level for curative effect
指标 截断值 AUC 敏感度(%) 特异性(%) 95%CI P ADC值 1.24×10-3 mm2/s 0.587 43.8 83.0 0.466~0.709 0.014 ApoA-1 1.06 g/L 0.786 68.8 79.5 0.701~0.872 < 0.001 两指标联合 - 0.899 96.9 69.3 0.838~0.960 < 0.001 -
[1] Osmani L, Askin F, Gabrielson E, et al. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy[J]. Semin Cancer Biol, 2018, 52(pt 1): 103-9. http://europepmc.org/abstract/MED/29183778 [2] Munoz-Schuffenegger P, Kandel S, Alibhai Z, et al. A prospective study of magnetic resonance imaging assessment of post-radiation changes following stereotactic body radiation therapy for non-small cell lung cancer[J]. Clin Oncol: R Coll Radiol, 2019, 31(10): 720-7. doi: 10.1016/j.clon.2019.05.014 [3] Tyagi N, Cloutier M, Zakian K, et al. Diffusion-weighted MRI of the lung at 3T evaluated using echo-planar-based and single-shot Turbo spin-echo-based acquisition techniques for radiotherapy applications[J]. J Appl Clin Med Phys, 2019, 20(1): 284-92. doi: 10.1002/acm2.12493 [4] 盛俊卿, 李卫星, 贾祯, 等. 多层螺旋CT灌注成像联合血清CYFRA21-1、CEA、NSE对周围型非小细胞肺癌的诊断价值[J]. 解放军医学杂志, 2020, 45(5): 542-6. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202005015.htm [5] 张英兰. 子宫内膜癌患者生存预后分析及早期筛查[D]. 北京: 北京协和医学院, 2016. [6] 李香营, 韩向君, 杨光, 等. 多b值DWI联合PSA评估前列腺癌内分泌治疗效果及相关性研究[J]. 实用放射学杂志, 2017, 33(9): 1390-3. doi: 10.3969/j.issn.1002-1671.2017.09.017 [7] 周彩存, 陈晓霞. 非小细胞肺癌维持治疗的争议与共识[J]. 中华结核和呼吸杂志, 2012, 35(2): 91-3. doi: 10.3760/cma.j.issn.1001-0939.2012.02.005 [8] Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1[) J]. Eur J Cancer, 2009, 45(2): 228-47. doi: 10.1016/j.ejca.2008.10.026 [9] Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer[J]. Nature, 2018, 553 (7689): 446-54. doi: 10.1038/nature25183 [10] Ke W, Zhang L, Dai Y. The role of IL-6 in immunotherapy of non-small cell lung cancer (NSCLC) with immune-related adverse events (irAEs)[J]. Thorac Cancer, 2020, 11(4): 835-9. doi: 10.1111/1759-7714.13341 [11] Yin Y, Sedlaczek O, Müller B, et al. Tumor cell load and heterogeneity estimation from diffusion-weighted MRI calibrated with histological data: an example from lung cancer[J]. IEEE Trans Med Imaging, 2018, 37(1): 35-46. doi: 10.1109/TMI.2017.2698525 [12] Iima M, Partridge SC, Le Bihan D. Six DWI questions You always wanted to know but were afraid to ask: clinical relevance for breast diffusion MRI[J]. Eur Radiol, 2020, 30(5): 2561-70. doi: 10.1007/s00330-019-06648-0 [13] Sampath S, Rahmanuddin S, Sahoo P, et al. Change in apparent diffusion coefficient is associated with local failure after stereotactic body radiation therapy for non-small cell lung cancer: a prospective clinical trial[J]. Int J Radiat Oncol, 2019, 105(3): 659-63. doi: 10.1016/j.ijrobp.2019.06.2536 [14] Filograna L, Magarelli N, Cellini F, et al. Diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) values for detection of malignant vertebral bone marrow lesions[J]. Eur Rev Med Pharmacol Sci, 2018, 22(3): 590-7. http://www.researchgate.net/publication/323318264_Diffusion_weighted_imaging_DWI_and_apparent_diffusion_coefficient_ADC_values_for_detection_of_malignant_vertebral_bone_marrow_lesions [15] Mori N, Mugikura S, Miyashita M, et al. Turbo Spin-echo Diffusion-weighted imaging compared with Single-shot Echoplanar Diffusion-weighted imaging: image quality and diagnostic performance when differentiating between ductal carcinoma in situ and invasive ductal carcinoma[J]. Magn Reson Med Sci, 2021, 20 (1): 60-8. doi: 10.2463/mrms.mp.2019-0195 [16] 李花, 宋琼, 马宝新, 等. 磁共振弥散加权成像对局部晚期非小细胞肺癌同步放化疗疗效预测价值[J]. 中华肿瘤防治杂志, 2020, 27(14): 1171-6. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL202014013.htm [17] 王玥, 郑秀妍, 江滕, 等. Ⅰ型子宫内膜样癌中ABCA1、ApoA1及SR-B1的表达及意义[J]. 临床与实验病理学杂志, 2020, 36(5): 583-6. https://www.cnki.com.cn/Article/CJFDTOTAL-LSBL202005028.htm [18] Jia ZH, Jia Y, Guo FJ, et al. Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer[J]. PLoS One, 2017, 12(8): e0183622. doi: 10.1371/journal.pone.0183622 [19] 邢红宇, 黄淑玲, 卓书伟, 等. 血清载脂蛋白A1及B对老年肝细胞癌患者术后生存率的预测价值[J]. 中国老年学杂志, 2020, 40(20): 4297-300. doi: 10.3969/j.issn.1005-9202.2020.20.013 [20] 苏晓芳, 郭凌宏, 黄文华. 小细胞肺癌的生物学研究及其临床治疗进展[J]. 分子影像学杂志, 2018, 41(4): 488-92. doi: 10.12122/j.issn.1674-4500.2018.04.16 [21] 魏建莹, 孙巍, 刘晓民, 等. TACE联合RFA治疗前血清ApoA1水平对肝细胞癌预后的影响[J]. 胃肠病学和肝病学杂志, 2020, 29(1): 22-6. doi: 10.3969/j.issn.1006-5709.2020.01.005 [22] 贺小平, 苗重昌, 周莹, 等. DWI与血清肿瘤标志物评价非小细胞肺癌化疗疗效的对比研究[J]. 临床放射学杂志, 2019, 38(7): 1213-8. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFS201907014.htm [23] 许华, 陈士新, 付伟, 等. 磁共振动态对比增强及弥散加权成像预测乳腺癌前哨淋巴结转移的价值[J]. 分子影像学杂志, 2020, 43(4): 721-5. doi: 10.12122/j.issn.1674-4500.2020.04.38